Guardant Health, Inc.
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Shield Post-Approval Study Protocol (NCT06880055) | Guardant Health, Inc. | 2025-07-14 |
| SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation (NCT05935384) | Guardant Health, Inc. | 2023-10-25 |
| Screening for High Frequency Malignant Disease (NCT05117840) | Guardant Health, Inc. | 2022-01-13 |
| ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (NCT05059444) | Guardant Health, Inc. | 2021-09-07 |
| Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer (NCT04436393) | Guardant Health, Inc. | 2020-07-02 |
| Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (NCT04136002) | Guardant Health, Inc. | 2019-10-08 |
| Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records (NCT03625557) | Guardant Health, Inc. | 2019-04-30 |
| Registry of Guardant360® Use and Outcomes In People With Advanced Cancer (NCT03477474) | Guardant Health, Inc. | 2018-04-06 |
Track Guardant Health, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.